Key facts
- It has raised $2.3M across 1 recorded rounds; the latest was Seed Round ($2.0M) in Jul 2022.
- Notable investors include SC Launch, South Carolina Research Authority.
- ElectroWire has filed 4 Form Ds with the SEC since 2022, most recently Jul 2025 ($2.0M sold to 29 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ElectroWire
Funding rounds
1 roundsAbout ElectroWire
Developer of electrosurgical medical devices intended to improve catheter-based transseptal access in cardiac interventions. The company platform offers powered, needle-free transseptal puncture technology, electrosurgical cardiac-access systems, and related procedural tools, providing hospitals and interventional cardiologists seeking safer and more efficient atrial access with enhanced precision, reduced procedural complexity, improved workflow reliability, and greater accessibility for high-volume cardiac procedures globally
- Sector
- Healthcare
- HQ
- Lexington, SC, United States
- Founded
- 2022
- Employees
- 6
- Website
- electrowiremedical.com/
- Ownership
- Privately Held (backing)
ElectroWire doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ElectroWire shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ElectroWire in its N-PORT filings yet. We sweep new filings monthly.